Martin C. Michel, AMC, Amsterdam, The Netherlands, Christopher R. Chapple, Royal Hallamshire Hospital, Sheffield, United Kingdom
Objective: The cardiovascular (CV) effects of tamsulosin oral controlled absorption system (OCAS®) 0.4mg were compared with those of alfuzosin prolonged release (XL) 10mg.
Objective: The cardiovascular (CV) effects of tamsulosin oral controlled absorption system (OCAS®) 0.4mg were compared with those of alfuzosin prolonged release (XL) 10mg.
Your session will expire in 8 hours requiring you to log in each day to view content.